Mitochondrial defects in cancer

le Carew Jennifer S, Huang Peng
Foilsithe 2002-12-01

Mitochondrial defects in cancer

le Carew, Jennifer S, Huang, Peng
Foilsithe 2002

Drain the lysosome: Development of the novel orally available autophagy inhibitor ROC-325

le Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Autophagy (2017)

Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance

le Nawrocki, Steffan T., Wang, Wei, Carew, Jennifer S.
Foilsithe in Cancers (Basel) (2020)

Autophagy as a target for cancer therapy: new developments

le Carew, Jennifer S, Kelly, Kevin R, Nawrocki, Steffan T
Foilsithe 2012

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy

le Jones, Trace M., Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Cancers (Basel) (2020)

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

le Carew, Jennifer S, Nawrocki, Steffan T, Giles, Francis J, Cleveland, John L
Foilsithe 2008

Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

le Swords, Ronan, Mahalingam, Devalingam, Padmanabhan, Swaminathan, Carew, Jennifer, Giles, Francis
Foilsithe 2009

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer

le Jones, Trace M., Carew, Jennifer S., Bauman, Julie E., Nawrocki, Steffan T.
Foilsithe in Cancers (Basel) (2021)

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

le Jones, Trace M., Espitia, Claudia, Wang, Wei, Nawrocki, Steffan T., Carew, Jennifer S.
Foilsithe in Cancer Commun (Lond) (2019)

Oncolytic Viruses for Multiple Myeloma Therapy

le Calton, Christine M., Kelly, Kevin R., Anwer, Faiz, Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Cancers (Basel) (2018)

Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy

le Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Blood Adv (2020)

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

le Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Viruses (2021)

Disruption of autophagic degradation with ROC-325 antagonizes renal cell carcinoma pathogenesis

le Carew, Jennifer S., Espitia, Claudia M., Zhao, William, Han, Yingchun, Visconte, Valeria, Phillips, James, Nawrocki, Steffan T.
Foilsithe in Clin Cancer Res (2016)

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

le Carew, Jennifer S., Espitia, Claudia M., Zhao, Weiguo, Mita, Monica M., Mita, Alain C., Nawrocki, Steffan T.
Foilsithe in Oncotarget (2017)

Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity

le Carew, Jennifer S., Espitia, Claudia M., Zhao, Weiguo, Visconte, Valeria, Anwer, Faiz, Kelly, Kevin R., Nawrocki, Steffan T.
Foilsithe in Blood Adv (2019)

Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ

le Achanta, Geetha, Sasaki, Ryohei, Feng, Li, Carew, Jennifer S, Lu, Weiqin, Pelicano, Helene, Keating, Michael J, Huang, Peng
Foilsithe 2005

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL

le Carew, Jennifer S., Nawrocki, Steffan T., Krupnik, Yelena V., Dunner, Kenneth, McConkey, David J., Keating, Michael J., Huang, Peng
Foilsithe 2006

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

le Kelly, Kevin R, Ecsedy, Jeffrey, Medina, Ernest, Mahalingam, Devalingam, Padmanabhan, Swaminathan, Nawrocki, Steffan T, Giles, Francis J, Carew, Jennifer S
Foilsithe in J Cell Mol Med (2011)

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus

le Kelly, Kevin R., Espitia, Claudia M., Zhao, Weiguo, Wendlandt, Erik, Tricot, Guido, Zhan, Fenghuang, Carew, Jennifer S., Nawrocki, Steffan T.
Foilsithe in Oncotarget (2015)